APTEKA N7, OOO, Moscow

Economic indicators

Net profit (RAS) of APTEKA N7, OOO grew over 2023 by 37.50% to 11.00 thousand RUB from 8.00 thousand RUB over 2022, the company informed.

Revenue decreased in the accounting period by 27.88% to 15.63 million RUB from 21.67 million RUB in 2022.

Net profit (RAS) of APTEKA N7, OOO grew over 2022 2.67 times to 8.00 thousand RUB from 3.00 thousand RUB over 2021, the company informed.

Revenue decreased in the accounting period by 5.23% to 21.67 million RUB from 22.86 million RUB in 2021.

Net profit (RAS) of APTEKA N7, OOO grew over 2021 1.50 times to 3.00 thousand RUB from 2.00 thousand RUB over 2020, the company informed.

Revenue decreased in the accounting period by 12.88% to 22.86 million RUB from 26.24 million RUB in 2020.

Net profit (RAS) of APTEKA N7, OOO over 2020 was the same as in 2019 reaching 2.00 thousand RUB, the company informed.

Revenue decreased in the accounting period by 1.82% to 26.24 million RUB from 26.73 million RUB in 2019.

Net profit (RAS) of APTEKA N7, OOO dropped in 2019 1,204.00 times to 2.00 thousand RUB from 2.41 million RUB over the same period in 2018, the company informed.

Revenue decreased in the accounting period by 1.78% to 26.73 million RUB from 27.21 million RUB in 2018.

Net profit (RAS) of APTEKA N7, OOO dropped in 2016 19.84 times to 49.00 thousand RUB from 972.00 thousand RUB over the same period in 2015, the company informed.

Revenue decreased in the accounting period by 5.97% to 27.47 million RUB from 29.22 million RUB in 2015; cost of goods sold decreased by 3.13% to 26.95 million RUB from 27.82 million RUB; sales profit fell 2.69 times to 518.00 thousand RUB from 1.39 million RUB.

Companies in the region

• VAYERS YUNION
• INNOVATSIONNYE TEKHNOLOGII
• KRAYTEKS
• FENIKS
• SATEDZHI